Receptor BioLogix, Inc. Company Profile

14:51 EDT 20th September 2018 | BioPortfolio

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.


1140 Veterans Boulevard, Suite A
South San Francisco
United States of America


Phone: (650) 266-4600
Fax: (650) 952-2205

News Articles [494 Associated News Articles listed on BioPortfolio]

5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

Symptomatic benefits have been reported for 5-HT6 receptor antagonists in Alzheimer’s disease (AD) trials. SAM-760 is a potent and selective 5-HT6 receptor antagonist that has demonstrated central 5...

Olfactory receptor as therapeutic target in bladder cancer

(Ruhr-University Bochum) Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis. Using cell culture studies, ...

Smell receptor fuels prostate cancer progression

(Duke University) Researchers have found that an olfactory receptor plays a critical role in the progression of prostate cancer. They found that activating the receptor -- called OR51E2 -- in prostate...

Tumors Shrink, or Grow, Depending on Drug Receptor–Receptor Effect

Though inhibited by a drug, a cancer-promoting cell receptor may stage a comeback, becoming part of a receptor-receptor pair that signals cancer cells to proliferate, should growth factors be present....

Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis

Anti-NMDA receptor encephalitis (ANRE) is a potentially lethal disease attributed to auto-antibodies against the N-methyl-D-aspartate receptor (NMDAR). Full recovery is possible if therapy is initiate...

Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Teveten [Abbott Laboratories]

TEVETEN (eprosartan mesylate) 400mg 600mg

Blocadren(timolol maleate)tablets [Merck & Co., Inc.]


Teveten hct [Abbott Laboratories]

TEVETEN HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg

Teveten hct [Physicians Total Care, Inc.]

TEVETEN HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg

Diovan [Novartis Pharmaceuticals Corporation]


PubMed Articles [1470 Associated PubMed Articles listed on BioPortfolio]

Research progress on significance of androgen receptor and epidermal growth factor receptor expression in estrogen receptor-negative and progesterone receptor-negative breast cancer.

Finding a ribophagy receptor.

Although ribophagy was demonstrated in budding yeast a decade ago, a specific receptor for this process has been unknown. Recently, a study revealed that NUFIP1 (nuclear FMR1 interacting protein 1) fu...

Emerging strategies targeting cb cannabinoid receptor: biased agonism and allosterism.

During these last years, the CB cannabinoid receptor has emerged as a potential anti-inflammatory target in diseases such as multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, is...

Progesterone receptor is responsible for the benign biology of skull base meningioma.

Many studies have been performed to evaluate the roles of estrogen receptor (ER) and progesterone receptor (PGR) in meningiomas, but their influence on tumor behavior remains unclear.

NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.

Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand of a Gi protein-coupled receptor named NOP. Both N/OFQ and NOP receptor are widely expressed in brain areas involved in the control of emotional...

Clinical Trials [1946 Associated Clinical Trials listed on BioPortfolio]

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Anti-NMDA receptor encephalitis is the most common curable non-infectious autoimmune encephalitis,but because of the lack of recognition in the clinic, usually been misdiagnosed as other...

Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist

Delinieation of GIP's effects during an oral glucose tolerance test (OGTT) in humans using GIP receptor antagonisation.

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

The investigators' proposed phase 2 clinical trial will be an open-label, non-randomized study among 80 women with metastatic breast cancer. The study treatment period will be up to twelve...

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain

We would like to evaluate the changes in nerve innervation and TRPV1 receptor expression along with microscopic changes associated with heart burn and abdominal pain

Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation

The purpose of this study is to show that PET-MR imaging can be used for obtaining a pharmacodynamic profile of drugs. By using the 5-HT1B receptor as target we also aim to find effect are...

Companies [147 Associated Companies listed on BioPortfolio]

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Receptor BioLogix

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Florida Biologix

Florida Biologix® is a Phase I/II biologics contract development, manufacturing and testing organization that offers a range of biopharmaceutical services to the biotech...

Millenium Biologix Corporation

Millenium Biologix Corporation is a leading biomedical company, developing and supplying innovative products for Regenerative Medicine in the field of skeletal disease and trauma, covering clinical an...

Millenium Biologix Incorporated

Millenium Biologix Inc. is a medical biotechnology company specializing in the commercialization of innovative products based on a proprietary synthetic bone technology. These advanced BioBone product...

More Information about "Receptor BioLogix, Inc." on BioPortfolio

We have published hundreds of Receptor BioLogix, Inc. news stories on BioPortfolio along with dozens of Receptor BioLogix, Inc. Clinical Trials and PubMed Articles about Receptor BioLogix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Receptor BioLogix, Inc. Companies in our database. You can also find out about relevant Receptor BioLogix, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record